Guangzhou Wondfo Biotech Co.,Ltd

SZSE:300482 Stock Report

Market Cap: CN¥10.1b

Guangzhou Wondfo BiotechLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zhongxiong Peng

Chief executive officer

CN¥1.6m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.2%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Doing What It Can To Lift Shares

Feb 17
Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Doing What It Can To Lift Shares

These 4 Measures Indicate That Guangzhou Wondfo BiotechLtd (SZSE:300482) Is Using Debt Safely

Jan 17
These 4 Measures Indicate That Guangzhou Wondfo BiotechLtd (SZSE:300482) Is Using Debt Safely

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Nov 18
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 01
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Sep 06
Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Jul 27
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Apr 29
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

Mar 27
A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Feb 29
There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

CEO

Zhongxiong Peng (50 yo)

2.3yrs
Tenure
CN¥1,577,900
Compensation

Mr. Zhongxiong Peng is General Manager of Guangzhou Wondfo Biotech Co.,Ltd. since January 19, 2023. He was Deputy General Manager of Guangzhou Wondfo Biotech Co.,Ltd and serves as its Director since June 1...

Board Members

NamePositionTenureCompensationOwnership
Zhongxiong Peng
GM & Director3.9yrsCN¥1.58m0.23%
CN¥ 23.6m
Yaping Zhao
Deputy General Manager & Non-Independent Directorless than a yearCN¥1.44m0.23%
CN¥ 23.6m
Ji Hua Wang
Chairmanno dataCN¥1.71m10.38%
CN¥ 1.0b
Xiao Wei He
Non-Employee Supervisorless than a yearCN¥1.04m0.073%
CN¥ 7.3m
Xinhua Ge
Non-Employee Supervisorless than a yearno datano data
Zhaohui Duan
Independent Directorno datano data0.000030%
CN¥ 3.0k
Congdong Li
Independent Directorno dataCN¥80.00kno data
Qingmei Song
Supervisorno datano datano data
Dali Li
Non-Independent Directorless than a yearCN¥1.42mno data
Ouyang Wenjin
Independent Directorless than a yearCN¥43.70kno data
0.9yrs
Average Tenure
52.5yo
Average Age

Experienced Board: 300482's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/25 21:02
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangzhou Wondfo Biotech Co.,Ltd is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Jingwei QiChina Merchants Securities Co. Ltd.
Shuo SongCitic Securities Co., Ltd.